These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 23726411)
1. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. Marshall AJ; Lin JM; Grey A; Reid IR; Cornish J; Denny WA Bioorg Med Chem; 2013 Jul; 21(14):4112-9. PubMed ID: 23726411 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of substituted triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis. Park SK; Oh S; Shin HK; Kim SH; Ham J; Song JS; Lee S Bioorg Med Chem Lett; 2011 Jun; 21(12):3573-7. PubMed ID: 21570847 [TBL] [Abstract][Full Text] [Related]
3. Reaction of 3-Amino-1,2,4-Triazole with Diethyl Phosphite and Triethyl Orthoformate: Acid-Base Properties and Antiosteoporotic Activities of the Products. Miszczyk P; Wieczorek D; Gałęzowska J; Dziuk B; Wietrzyk J; Chmielewska E Molecules; 2017 Feb; 22(2):. PubMed ID: 28208725 [TBL] [Abstract][Full Text] [Related]
4. Application of click chemistry towards an efficient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors. Anand N; Jaiswal N; Pandey SK; Srivastava AK; Tripathi RP Carbohydr Res; 2011 Jan; 346(1):16-25. PubMed ID: 21129735 [TBL] [Abstract][Full Text] [Related]
5. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Tyagi AM; Gautam AK; Kumar A; Srivastava K; Bhargavan B; Trivedi R; Saravanan S; Yadav DK; Singh N; Pollet C; Brazier M; Mentaverri R; Maurya R; Chattopadhyay N; Goel A; Singh D Mol Cell Endocrinol; 2010 Aug; 325(1-2):101-9. PubMed ID: 20570709 [TBL] [Abstract][Full Text] [Related]
6. Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption. Greig IR; Idris AI; Ralston SH; van't Hof RJ J Med Chem; 2006 Dec; 49(25):7487-92. PubMed ID: 17149877 [TBL] [Abstract][Full Text] [Related]
7. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957 [TBL] [Abstract][Full Text] [Related]
9. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Hinoi E; Takarada T; Uno K; Inoue M; Murafuji Y; Yoneda Y Am J Pathol; 2007 Apr; 170(4):1277-90. PubMed ID: 17392167 [TBL] [Abstract][Full Text] [Related]
10. Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo. Coxon FP; Ebetino FH; Mules EH; Seabra MC; McKenna CE; Rogers MJ Bone; 2005 Sep; 37(3):349-58. PubMed ID: 16006204 [TBL] [Abstract][Full Text] [Related]
11. Click chemistry: 1,2,3-triazoles as pharmacophores. Agalave SG; Maujan SR; Pore VS Chem Asian J; 2011 Oct; 6(10):2696-718. PubMed ID: 21954075 [TBL] [Abstract][Full Text] [Related]
12. The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. Yuan J; Akiyama M; Nakahama K; Sato T; Uematsu H; Morita I Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):85-90. PubMed ID: 20394833 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 5-halogenated 1,2,3-triazoles under stoichiometric Cu(I)-mediated azide-alkyne cycloaddition (CuAAC or 'Click Chemistry'). Goyard D; Praly JP; Vidal S Carbohydr Res; 2012 Nov; 362():79-83. PubMed ID: 23124169 [TBL] [Abstract][Full Text] [Related]
14. Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides. El Akri K; Bougrin K; Balzarini J; Faraj A; Benhida R Bioorg Med Chem Lett; 2007 Dec; 17(23):6656-9. PubMed ID: 17931862 [TBL] [Abstract][Full Text] [Related]
15. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639 [TBL] [Abstract][Full Text] [Related]
16. Caffeine enhances osteoclast differentiation from bone marrow hematopoietic cells and reduces bone mineral density in growing rats. Liu SH; Chen C; Yang RS; Yen YP; Yang YT; Tsai C J Orthop Res; 2011 Jun; 29(6):954-60. PubMed ID: 21284030 [TBL] [Abstract][Full Text] [Related]
17. "Click-and-click"--hybridised 1,2,3-triazoles supported Cu(I) coordination polymers for azide-alkyne cycloaddition. Jiang L; Wang Z; Bai SQ; Hor TS Dalton Trans; 2013 Jul; 42(26):9437-43. PubMed ID: 23695801 [TBL] [Abstract][Full Text] [Related]
18. l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan. Hall C; Wolfe H; Wells A; Chien HC; Colas C; Schlessinger A; Giacomini KM; Thomas AA Bioorg Med Chem Lett; 2019 Aug; 29(16):2254-2258. PubMed ID: 31248771 [TBL] [Abstract][Full Text] [Related]
19. Regulation of osteoclastogenesis by gap junction communication. Matemba SF; Lie A; Ransjö M J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710 [TBL] [Abstract][Full Text] [Related]
20. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Schindeler A; Little DG Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]